Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000082395 | SCV000055016 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000040185 | SCV000063876 | benign | not specified | 2017-10-23 | criteria provided, single submitter | clinical testing | The p.Pro10574Ser variant has been identified in 2% (101/5052) of South Asian c hromosomes, including 6 homozygotes, by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org). BA1 |
Labcorp Genetics |
RCV001083903 | SCV000286617 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000040185 | SCV000337399 | benign | not specified | 2018-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000082395 | SCV000977120 | benign | not provided | 2018-06-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Center for Advanced Laboratory Medicine, |
RCV000852867 | SCV000995601 | likely benign | Primary dilated cardiomyopathy | 2017-02-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001133068 | SCV001292754 | benign | Tibial muscular dystrophy | 2017-05-25 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001133069 | SCV001292755 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-05-25 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001133070 | SCV001292756 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2017-05-25 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001133071 | SCV001292757 | likely benign | Dilated cardiomyopathy 1G | 2017-05-25 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001136516 | SCV001296355 | likely benign | Early-onset myopathy with fatal cardiomyopathy | 2017-05-25 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000040185 | SCV004020317 | benign | not specified | 2023-06-01 | criteria provided, single submitter | clinical testing | Variant summary: TTN c.31720C>T (p.Pro10574Ser) results in a non-conservative amino acid change located in the I-band region of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0028 in 51728 control chromosomes, predominantly at a frequency of 0.02 within the South Asian subpopulation in the gnomAD database, including 6 homozygotes. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 31.99 fold of the estimated maximal expected allele frequency for a pathogenic variant in TTN causing Cardiomyopathy phenotype (0.00063), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. c.31720C>T has been reported in the literature in individuals affected with Cardiomyopathy (e.g., Pughes_2014), and at least one case of sudden unexplained death (e.g., Sanchez_2016), however without strong evidence for causality in all cases. These reports therefore do not provide unequivocal conclusions about association of the variant with Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 24503780, 27930701). Eight ClinVar submitters (evaluation after 2014) have cited the variant with conflicting assessments (benign, n = 5; likely benign, n = 2; VUS, n = 1). Based on the evidence outlined above, the variant was classified as benign. |
Laboratory of Diagnostic Genome Analysis, |
RCV000082395 | SCV001798144 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000040185 | SCV001917944 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000040185 | SCV001966539 | benign | not specified | no assertion criteria provided | clinical testing |